Search research articles
Contact Us
Filters
Showing results (411-420 of 606) with videos related to
Page
of 61
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindole
A Coop, J Pinto, L Wang, et al.
Circulation
|
January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
R B Rothman, M H Baumann, J E Savage, et al.
Neurology
|
February 1, 1979
Lymphocyte adherence in multiple sclerosis
P Dore-Duffy, R B Zurier, J Donaldson, et al.
Neuropeptides
|
December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditions
R B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands
B R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology
|
November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization
C E Groer, K Tidgewell, R A Moyer, et al.
Peptides
|
January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site
R B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research
|
February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development
S McLean, R B Rothman, D M Chuang, et al.
Journal of Substance Abuse Treatment
|
April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence
R B Rothman, D A Gorelick, S J Heishman, et al.
Synapse (New York, N.Y.)
|
March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice
Richard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Page
of 61
Search research articles
Search
Showing results (411-420 of 606) with videos related to
Sort By:
Page
of 61
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindole
A Coop, J Pinto, L Wang, et al.
Circulation
|
January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
R B Rothman, M H Baumann, J E Savage, et al.
Neurology
|
February 1, 1979
Lymphocyte adherence in multiple sclerosis
P Dore-Duffy, R B Zurier, J Donaldson, et al.
Neuropeptides
|
December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditions
R B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands
B R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology
|
November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization
C E Groer, K Tidgewell, R A Moyer, et al.
Peptides
|
January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site
R B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research
|
February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development
S McLean, R B Rothman, D M Chuang, et al.
Journal of Substance Abuse Treatment
|
April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence
R B Rothman, D A Gorelick, S J Heishman, et al.
Synapse (New York, N.Y.)
|
March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice
Richard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Page
of 61